Isolation of a new phenazine antibiotic, DOB-41, from Pseudomonas species. 1988

J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.

A new phenazine antibiotic, DOB-41, was isolated from the culture broth of a Pseudomonas strain. The antibiotic obtained as yellow crystals showed UV maxima at 255 nm and 370 nm. A molecular formula, C19H18N2O6, was indicated by elemental analysis and mass spectrometry. The structure was elucidated by X-ray diffraction analysis. The antibiotic exhibited inhibitory activity against Gram-positive bacteria, and antitumor effect against leukemia P388 in mice.

UI MeSH Term Description Entries
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D010619 Phenazines
D011549 Pseudomonas A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants. Chryseomonas,Pseudomona,Flavimonas
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D013057 Spectrum Analysis The measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Spectroscopy,Analysis, Spectrum,Spectrometry
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions

Related Publications

J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
August 1976, The Journal of antibiotics,
J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
October 1987, The Journal of antibiotics,
J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
April 1990, Applied and environmental microbiology,
J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
August 1988, Journal of bacteriology,
J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
March 1970, Journal of the American Chemical Society,
J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
December 1996, The Journal of antibiotics,
J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
December 1987, Antimicrobial agents and chemotherapy,
J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
January 2008, Mikrobiologiia,
J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
December 1957, Canadian journal of microbiology,
J Shoji, and R Sakazaki, and H Nakai, and Y Terui, and T Hattori, and O Shiratori, and E Kondo, and T Konishi
April 1981, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!